VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DaiS who wrote (9404)	6/10/1998 10:53:00 AM
From: Sal Milani	Read Replies (1) of 23519

DaiS, I am surprised that for those who find that Viagra does not work, only 1 in 5 would try MUSE. <<I think this (.5) is too optimistic for reasons already given by others on the thread. Let's say 20% of 84000 instead>> These are men who are concerned enough about their condition to see an MD. If they are willing to risk life and sight for a pill why would they turn their backs on MUSE ? Could you repeat the reasons for this value ? <<Of those it works for 10% stick to it (dropouts/cures?)>> The Vivus studies showed a 65% success rate with "one third of men reporting genital pain, causing some to stop". This would indicate a value of more than .4. How did you arrive at .1 ? Sal

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next